Sunshine Biopharma (SBFMW) EBT Margin Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFMW) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1,840.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -134.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,686.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 5,487.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -225.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -15,283.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 4,514.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 25,271.00 |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 1,846.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,846.00 |
| Dec 31, 2025 | 57,066.00 |
| Sep 30, 2025 | 108,624.00 |
| Jun 30, 2025 | 33,747.00 |
| Mar 31, 2025 | 99,427.00 |
| Dec 31, 2024 | -73,994.00 |
| Sep 30, 2024 | 800,682.00 |
| Jun 30, 2024 | 543,611.00 |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 385,549.00 |
| Sep 30, 2023 | 406,319.00 |
| Jun 30, 2023 | 597,706.00 |
| Mar 31, 2023 | 81,519.00 |
| Dec 31, 2022 | 316,641.00 |
| Sep 30, 2022 | 368,371.00 |
| Jun 30, 2022 | 395,289.00 |
| Mar 31, 2022 | 9.63 Mn |
| Mar 31, 2021 | -1.52 Mn |